QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors

Clinical trial NCT01106248 · COMPLETED

Trial details

NCT number: NCT01106248
Sponsor: Eisai Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2009-03-01
Primary completion: 2010-09-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.